Skip to main content

Advertisement

Log in

Giant cell tumour of the sacrum: a suggested algorithm for treatment

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

To investigate the outcome of our management of patients with giant cell tumour of the sacrum and draw lessons from this. A retrospective review of medical records and scans for all patients treated at our unit over the past 20 years with a giant cell tumour of the sacrum. Of the 517 patients treated at our unit for giant cell tumour over the past 20 years, only 9 (1.7%) had a giant cell tumour in the sacrum. Six were female, three male with a mean age of 34 (range 15–52). All, but two tumours involved the entire sacrum and there was only one purely distal to S3. The mean size was 10 cm and the most common symptom was back or buttock pain. Five had abnormal neurology at diagnosis, but only one presented with cauda equina syndrome. The first four patients were treated by curettage alone, but two patients had intraoperative cardiac arrests and although both survived all subsequent curettages were preceded by embolisation of the feeding vessels. Of the seven patients who had curettage, three developed local recurrence, but all were controlled with a combination of further embolisation, surgery or radiotherapy. One patient elected for treatment with radiotherapy and another had excision of the tumour distal to S3. All the patients are alive and only two patients have worse neurology than at presentation, one being impotent and one with stress incontinence. Three patients required spinopelvic fusion for sacral collapse. All patients are mobile and active at a follow-up between 2 and 21 years. Giant cell tumour of the sacrum can be controlled with conservative surgery rather than subtotal sacrectomy. The excision of small distal tumours is the preferred option, but for larger and more extensive tumours conservative management may well avoid morbidity whilst still controlling the tumour. Embolisation and curettage are the preferred first option with radiotherapy as a possible adjunct. Spinopelvic fusion may be needed when the sacrum collapses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Szendroi M (2004) Giant cell tumour of bone. J Bone Joint Surg [Br] 86-B:5–12

    Google Scholar 

  2. Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ (2005) Does curettage without adjuvant therapy provide low recurrence rates in giant cell tumours of bone? Clin Orthop 435:211–218

    PubMed  Google Scholar 

  3. Turcotte RE, Wunder JS, Isler MH et al (2002) Giant cell tumour of long bone: a Canadian Sarcoma Group study. Clin Orthop 397:248–258

    Article  PubMed  Google Scholar 

  4. Caudell JJ, Ballo MT, Zagars GK et al (2003) Radiotherapy in the management of giant cell tumour of bone. Int J Radiat Oncol Biol Phys 57:158–165

    PubMed  Google Scholar 

  5. Leggon RE, Zlotecki R, Reith J, Scarborogh MT (2004) Giant cell tumour of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop 423:196–207

    Article  PubMed  Google Scholar 

  6. Lackman RD, Khoury LD, Esmail A, Donthineni-Rao R (2002) The treatment of sacral giant cell-tumours by serial arterial embolisation. J Bone Joint Surg [Br] 84-B:873–877

    Article  Google Scholar 

  7. Hosalkar HS, Jones KJ, King JJ, Lackman RD (2007) Serial arterial embolization for large sacral giant cell tumours: mid to long term results. Spine 32:1107–1115

    Article  PubMed  Google Scholar 

  8. Lin PP, Guzel VB, Moura MF et al (2002) Long term follow up of patients with giant cell tumour of the sacrum treated with selective arterial embolization. Cancer 95:1317–1325

    Article  PubMed  Google Scholar 

  9. Chakravarti A, Spiro IJ, Hug EB et al (1999) Megavoltage radiation therapy for axial and inoperable giant cell tumour of bone. J Bone Joint Surg [Am] 81-A:1566–1573

    Google Scholar 

  10. Shen FH, Harper M, Foster WC, Marks I, Arlet V (2006) A novel “Four rod technique” for lumbo-pelvic reconstruction: theory and technical considerations. Spine 31:1395–1401

    Article  PubMed  Google Scholar 

  11. Doita M, Harada T, Iquchi T et al (2003) Total sacrectomy and reconstruction for sacral tumours. Spine 28:E296–E301

    Article  PubMed  Google Scholar 

  12. Wuisman P, Lieshout O, Sugihara S, van Dijk M (2000) Total sacrectomy and reconstruction: oncologic and functional outcome. Clin Orthop 381:192–203

    Article  PubMed  Google Scholar 

  13. Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH (1994) Conservative surgery for giant cell tumours of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer 74:1253–1260

    Article  CAS  PubMed  Google Scholar 

  14. Chang SS, Suratwala SJ, Jung KM et al (2004) Bisphosphonates may reduce recurrence in giant cell tumour by inducing apoptosis. Clin Orthop 426:103–109

    Article  PubMed  Google Scholar 

  15. Thomas D, Chawla SP, Skubitz K, Staddon AP, Her Jun R (2008) Denosumab treatment of giant cell tumour of bone: interim analysis. http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=55&abstractID=30432. Accessed August 2008

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajkumar Thangaraj.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thangaraj, R., Grimer, R.J., Carter, S.R. et al. Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J 19, 1189–1194 (2010). https://doi.org/10.1007/s00586-009-1270-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-009-1270-8

Keywords

Navigation